What is Klone Lab?
Klone Lab operates as a global leader in full-service licensing, specializing in the design, manufacture, and distribution of sport and lifestyle sandals, golf footwear, and biomechanical footwear. The company excels in partnering with sports and lifestyle brands, leveraging over 55 years of experience to enhance brand portfolios and broaden market reach. KloneLab also cultivates its own lifestyle brands, such as Revitalign, which features biomechanically engineered footwear for active consumers. Their comprehensive service offering encompasses licensing, brand development, and end-to-end design and sourcing solutions for athletic and lifestyle footwear.
How much funding has Klone Lab raised?
Klone Lab has raised a total of $349K across 2 funding rounds:
Debt
$150K
Debt
$199K
Debt (2020): $150K with participation from PPP
Debt (2021): $199K led by PPP
What's next for Klone Lab?
The company's recent large-scale, late-stage funding, characterized as a major strategic investment, signals a pivotal moment for Klone Lab. This influx of capital is likely earmarked for accelerating market penetration, expanding its product lines, and potentially exploring new technological advancements in biomechanical footwear. The strategic nature of this financing suggests a focus on synergistic growth, possibly involving deeper collaborations with existing brand partners or the acquisition of complementary businesses. Klone Lab is poised to solidify its leadership in the specialized footwear market.
See full Klone Lab company page
